Diagnosis of advanced cervical cancer, missed opportunities? - Inserm - Institut national de la santé et de la recherche médicale Access content directly
Journal Articles BMC Women's Health Year : 2022

Diagnosis of advanced cervical cancer, missed opportunities?


Background: Cervical cancer is common worldwide. Despite the existence of primary and secondary prevention strategies, the survival rate is decreasing in France due to an increasing proportion of advanced-stage cancer. Our objective was to determine the factors associated with a diagnosis of cervical cancer at advanced stages in an urban population in France. Methods: A retrospective study was conducted on all consecutive records of patients diagnosed with cervical cancer between January 2006 and December 2018 in a single center in Paris. The data collected were demographic characteristics, medical and gynecological history, circumstances of diagnosis, diagnostic and therapeutic management. The patients were divided into two groups according to the FIGO 2018 stage at diagnosis: group A stages IA1 to IB2 and group B advanced stages IB3 to IVB. Results: Among 96 patients who were diagnosed with cervical cancer, 25 (26%) were in group A and 71 (74%) in group B. Women in group B had less frequently received regular gynecological care than in group A (36% vs 84.2%, p < 0.001) and fewer had Pap test screening in the previous 3 years (30.4% vs 95.0%, p < 0.001). Parity greater than 3 was more frequent in group B (69.6% vs 42.9%, p = 0.031). The diagnosis was made during a routine examination or cervical smear in only 9.23% and 16.18% respectively in group B, versus 60% of cases in 45.82% of cases in group A (p < 0.001 and p = 0.003). Vaginal bleeding was observed in 85.29% in group B versus 36% in group A (p < 0.001). Histological type was squamous cell carcinoma 87.32% of group B and 56% of group A (p < 0.001). Conclusion: Diagnosis of cervical cancers at advanced stages occurred mostly in women who did not benefit from the recommended screening. Universal access to screening is necessary for the prevention and early treatment of cervical cancer.
Fichier principal
Vignette du fichier
s12905-022-01668-3.pdf (744.99 Ko) Télécharger le fichier
Origin : Publisher files allowed on an open archive

Dates and versions

inserm-03693125 , version 1 (10-06-2022)



Jérémie Mattern, Irène Letendre, Jeanne Sibiude, Cécile Pénager, Asma Jnifen, et al.. Diagnosis of advanced cervical cancer, missed opportunities?. BMC Women's Health, 2022, 22 (1), pp.97. ⟨10.1186/s12905-022-01668-3⟩. ⟨inserm-03693125⟩
8 View
11 Download



Gmail Facebook Twitter LinkedIn More